首页> 美国卫生研究院文献>Frontiers in Pharmacology >Applying a Global Sensitivity Analysis Workflow to Improve the Computational Efficiencies in Physiologically-Based Pharmacokinetic Modeling
【2h】

Applying a Global Sensitivity Analysis Workflow to Improve the Computational Efficiencies in Physiologically-Based Pharmacokinetic Modeling

机译:应用全球敏感性分析工作流,以提高基于生理的药代动力学建模的计算效率

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Traditionally, the solution to reduce parameter dimensionality in a physiologically-based pharmacokinetic (PBPK) model is through expert judgment. However, this approach may lead to bias in parameter estimates and model predictions if important parameters are fixed at uncertain or inappropriate values. The purpose of this study was to explore the application of global sensitivity analysis (GSA) to ascertain which parameters in the PBPK model are non-influential, and therefore can be assigned fixed values in Bayesian parameter estimation with minimal bias. We compared the elementary effect-based Morris method and three variance-based Sobol indices in their ability to distinguish “influential” parameters to be estimated and “non-influential” parameters to be fixed. We illustrated this approach using a published human PBPK model for acetaminophen (APAP) and its two primary metabolites APAP-glucuronide and APAP-sulfate. We first applied GSA to the original published model, comparing Bayesian model calibration results using all the 21 originally calibrated model parameters (OMP, determined by “expert judgment”-based approach) vs. the subset of original influential parameters (OIP, determined by GSA from the OMP). We then applied GSA to all the PBPK parameters, including those fixed in the published model, comparing the model calibration results using this full set of 58 model parameters (FMP) vs. the full set influential parameters (FIP, determined by GSA from FMP). We also examined the impact of different cut-off points to distinguish the influential and non-influential parameters. We found that Sobol indices calculated by eFAST provided the best combination of reliability (consistency with other variance-based methods) and efficiency (lowest computational cost to achieve convergence) in identifying influential parameters. We identified several originally calibrated parameters that were not influential, and could be fixed to improve computational efficiency without discernable changes in prediction accuracy or precision. We further found six previously fixed parameters that were actually influential to the model predictions. Adding these additional influential parameters improved the model performance beyond that of the original publication while maintaining similar computational efficiency. We conclude that GSA provides an objective, transparent, and reproducible approach to improve the performance and computational efficiency of PBPK models.
机译:传统上,在基于生理的药代动力学(PBPK)模型中降低参数维数的解决方案是通过专家判断。但是,如果将重要参数固定为不确定或不适当的值,则此方法可能会导致参数估计和模型预测出现偏差。这项研究的目的是探索全局敏感性分析(GSA)的应用,以确定PBPK模型中的哪些参数没有影响,因此可以在贝叶斯参数估计中为固定值分配最小的偏差。我们比较了基于基本效应的Morris方法和基于三个方差的Sobol指数,以区分估计的“有影响力”参数和固定的“无影响力”参数。我们使用对乙酰氨基酚(APAP)及其两个主要代谢物APAP-葡萄糖醛酸和APAP-硫酸盐的已发布的人PBPK模型说明了该方法。我们首先将GSA应用于原始发布的模型,使用所有21种原始校准的模型参数(OMP,由“专家判断”为基础的方法确定)贝叶斯模型的校准结果与原始影响参数(OIP,由GSA确定)的子集进行比较来自OMP)。然后,我们将GSA应用于所有PBPK参数,包括已发布模型中固定的PBPK参数,并使用全套58个模型参数(FMP)与全套影响参数(FIP,由GSA从FMP确定)比较模型校准结果。我们还检查了不同临界点的影响,以区分有影响力和无影响力的参数。我们发现,通过eFAST计算得出的Sobol指数在识别有影响力的参数时提供了可靠性(与其他基于方差的方法的一致性)和效率(实现收敛的最低计算成本)的最佳组合。我们确定了几个没有影响的最初校准的参数,这些参数可以进行固定以提高计算效率,而不会在预测准确性或精度上产生明显的变化。我们进一步发现了六个先前固定的参数,这些参数实际上对模型预测有影响。添加这些附加的有影响力的参数可以使模型性能超过原始出版物,同时保持相似的计算效率。我们得出的结论是,GSA提供了一种客观,透明和可重现的方法来改善PBPK模型的性能和计算效率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号